Sponsored By

Omega-3 Pharmaceutical Approved in Norway

January 14, 2002

1 Min Read
Omega-3 Pharmaceutical Approved in Norway


Omega-3 Pharmaceutical Approved in Norway

LYSAKER, Norway--OMACOR, a high-potency formulation ofomega-3s (EPA and DHA), was approved in Norway for the treatment of post-infarctpatients. It shows similar therapeutic effects to other cardiovascular therapiessuch as anti-hypertensives, statins and anti-platelets. The formulation has alsobeen approved in the United Kingdom, Germany, France, Austria and Greece. OMACORwas developed from research by Pronova Biocare (www.pronova.com).

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like